RVRC.US Revium Recovery Inc

Healthcare Health Care Technology USA Stocks
1.43 USD
Close of Oct 3, 2026
0.5200 1.67
Market cap
USD 86.8M
P/E
-
P/B
-
ROE
-0.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is RVRC.US undervalued?

Graham number

The Graham number of Revium Recovery Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Revium Recovery Inc fundamental analysis

No fundamental analysis for Revium Recovery Inc yet.

Revium Recovery Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Revium Recovery Inc

Revium Rx. operates as a pre-clinical stage biopharmaceutical company focused on the development of nanoparticle-based therapies in the United States. The company develops lipid-based platforms for a variety of uses including antimicrobial resistance and solid tumors; specializes in infectious diseases, including antibiotic-resistant infections, solid tumors, and vaccination; and develops nano-liposomal particles (NLP) based pharmaceutical candidates. It also offers Nano-Mup…

Full company profile